Search - tctmd.com

Displaying 1 - 20 of 585

Sort: Relevancy | Date

News Daily News

‘Appropriate’ Use of Revascularization in ACS: Updated Criteria Released at Last

Caitlin E. Cox

December 21, 2016

News Daily News

Multiple Antithrombotic Meds Before PCI in NSTE ACS Ups Bleeding Risk, Lowers Survival

Michael O'Riordan

December 13, 2016

News Industry News

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

November 29, 2016

News Daily News

Anemia Common in ACS Patients, Linked with Higher Mortality

Michael O'Riordan

November 23, 2016

News Conference News AHA 2016

Chest Pain Clinic Reduces Emergency Department and Hospital ‘Frequent Fliers’

Michael O'Riordan

November 21, 2016

News Conference News AHA 2016

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

Michael O'Riordan

November 15, 2016

AEGIS-I Trial: The Safety and Tolerability of CSL112

Presentation AHA 2016

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

Presenter: Michael Gibson

November 15, 2016

News Conference News AHA 2016

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Michael O'Riordan

November 14, 2016

News Conference News AHA 2016

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

Yael L. Maxwell

November 13, 2016

News Daily News

MILANO-PILOT Falters, Effectively Ending the ApoA-1 Milano Saga

Michael O'Riordan

November 09, 2016

News Industry News

Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016

November 03, 2016

Presentation TCT 2016

iFR in Acute Coronary Syndromes

Presenter: Nick Curzen, Nils Johnson, Justin E. Davies

November 01, 2016

News Industry News TCT 2016

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

November 01, 2016

Presentation TCT 2016

TCT 388: Sirolimus Coated Balloon in the Treatment of Acute Coronary Syndrome: Results from the Nanolutè Registry

Presenter: Germano Di Sciascio, Bruno Scheller

November 01, 2016

News Conference News TCT 2016

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

Michael H. Wilson

October 31, 2016

Presentation TCT 2016

TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Presenter: Michael J. Cowley, Franz-Josef Neumann, Shunsuke Kubo

October 31, 2016

Presentation TCT 2016

TCT 55: RiskBenefit Analysis of Upstream Antithrombotic Therapy in Patients With NonST-Segment Elevation Acute Coronary Syndromes Prior to Coronary Angiography

Presenter: Neal S. Kleiman, David F. Kong, Bjorn Redfors

October 31, 2016

News Conference News TCT 2016

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Michael O'Riordan

October 31, 2016

Presentation TCT 2016

The Netherlands Presents: Detection and Treatment of High-risk Plaques in ACS Patients

Presenter: Murat Sezer, Niels van Royen

October 31, 2016

Presentation TCT 2016

Do We Need New Technologies Beyond/Beside DES?

Presenter: Guy J. Friedrich, Kurt Huber, Stephane Cook

October 31, 2016

Advertisement

‘Appropriate’ Use of Revascularization in ACS: Updated Criteria Released at Last

Multiple Antithrombotic Meds Before PCI in NSTE ACS Ups Bleeding Risk, Lowers Survival

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

Anemia Common in ACS Patients, Linked with Higher Mortality

Chest Pain Clinic Reduces Emergency Department and Hospital ‘Frequent Fliers’

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

MILANO-PILOT Falters, Effectively Ending the ApoA-1 Milano Saga

Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016

iFR in Acute Coronary Syndromes

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

TCT 388: Sirolimus Coated Balloon in the Treatment of Acute Coronary Syndrome: Results from the Nanolutè Registry

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

TCT 55: RiskBenefit Analysis of Upstream Antithrombotic Therapy in Patients With NonST-Segment Elevation Acute Coronary Syndromes Prior to Coronary Angiography

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

The Netherlands Presents: Detection and Treatment of High-risk Plaques in ACS Patients

Do We Need New Technologies Beyond/Beside DES?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content